| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.26 | 0.4 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |